Categories: Clinical TrialNews

Back Pain, Prostatitis, Enlarged Prostate (BPH) and Kidney Stones are Treated with the Safest Thermobalancing Therapy

  • The first safe therapy with Dr Allen’s Device has once again proved its ability to reduce the size of an enlarged prostate, to dissolve kidneys stones and to provide low back pain relief.
  • Natural Thermobalancing therapy with Dr Allen’s Device is safe while standard long courses of painkillers, antibiotics for chronic prostatitis, BPH drugs and surgeries are risky.

OXFORD, UK / ACCESSWIRE / March 23, 2024 / Dr Allen’s Device ensures that the risk of unnecessary harm associated with standard treatment options is reduced to a minimum. Thermobalancing therapy is effective for reducing the size of an enlarged prostate in men with benign prostatic hyperplasia (BPH), eliminating the symptoms of chronic prostatitis and lower back pain, and dissolving kidneys stones.

“Thermobalancing therapy meets the Care Quality Commission (CQC) 5 Standards: Safe, Effective, Caring, Responsive and Well-Led,” says Dr Simon Allen, Director of Fine Treatment. “Thermobalancing therapy is a new patented method, effective and safe, for treating various chronic diseases, such as back pain and kidney stones, problems with the heart and prostate, joints and head.”

There are no safe medications for long-term use.

Medicines for chronic diseases, which are usually prescribed for life, have side effects. Moreover, these side effects accumulate, causing new health problems.

Thus, opioids and nonsteroidal anti-inflammatory drugs, acetaminophen and anticonvulsants for chronic low back pain can cause constipation, nausea, itching, dizziness, and new gastrointestinal and cardiovascular disorders.

Drugs for BPH and chronic prostatitis or chronic pelvic pain syndrome (CP/CPPS), α1-blockers and 5α-reductase inhibitors (5-ARIs) cause dizziness and asthenia, erectile dysfunction and sexual side effects, anxiety and depression.

Surgery for kidney stones.

Extracorporeal shock wave lithotripsy (ESWL, percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS) are surgeries to remove kidney stone(s). These interventions can cause serious complications in men and women, such as high blood pressure, diabetes, etc.

Clinical studies confirm the safety of Thermobalancing Therapy.

1. Clinical study on Thermobalancing therapy for lumbar disc herniation and non-specific low back pain:

Efficacy and safety of thermobalancing therapy with Dr Allen’s Device for chronic low back pain: A randomised controlled trial – PubMed (nih.gov)

2. Clinical study on Thermobalancing therapy for BPH and chronic prostatitis:

Innovative Thermobalancing therapy and Dr Allen’s Device for the first time employ body energy to treat chronic prostatic diseases effectively

3. Clinical study on Thermobalancing therapy for kidney stones:

Thermobalancing therapy with Dr Allen’s Device dissolves kidney stones improving health-related quality of life measured by the Wisconsin Stone Quality of Life questionnaire (WISQOL) – a randomised clinical trial

Dr Allen’s Device is the first safe treatment option for chronic diseases.

According to clinical studies, Dr Allen’s Device is completely safe and effective for people with chronic lower back pain caused by lumbar disc herniation and non-specific low back pain; for men with BPH and chronic prostatitis and for men and women with BPH and chronic prostatitis and chronic pelvic pain syndrome.

Dr Allen’s Device received the patent issued by USPTO. Thermobalancing therapy with Dr Allen’s Device is the safest intervention that helps people with a variety of chronic conditions avoid risky medications and surgeries.

Contact Information:

Alex Day
Customer Service Manager
Fine Treatment, Oxford, United Kingdom
Tel.: +447958878300
Email: info@finetreatment.com
www.finetreatment.com

SOURCE: Fine Treatment

View the original press release on accesswire.com

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

21 hours ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

1 day ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

1 day ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

1 day ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

2 days ago